Thus, by inhibiting the expression of fibronectinand its integrin α5β1, PPAR-γ ligands might reduce tumor cellrecognition of fibronectin with consequent changes in cell proliferation andapoptosis. This evidence concerns the gene PPARG and neoplasm.